EMBC EMBECTA CORP

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal fourth quarter and full year 2022 financial results, and provide an operational update, including preliminary fiscal year 2023 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, December 20, 2022.

Those who would like to participate may access the live webcast , or access the teleconference . The live webcast can also be accessed via the company’s website at .

A webcast replay of the call will be available beginning at 11:00 a.m. ET on December 20, 2022, via the embecta investor relations website and archived on the website for one year.

About embecta 

embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 

 

Investors:

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547

Media:

Christian Glazar

Sr. Director, Corporate Communications 

908-821-6922 



EN
03/11/2022

Underlying

EMBCEMBECTA CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Participate in Investor Events

embecta to Participate in Investor Events PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events: 2025 Wells Fargo Healthcare Conference Management will host a fireside session on Thursday, September 4, 2025, at 3:00 p.m. EDT and one-on-one investor meetings throughout the day at the Encore Boston Harbor Hotel, Boston. 2025 Morgan Stanley 23rd ...

21h / 8m 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025. "Q3 was a strong quarter for embecta, reflecting solid commercial execution, aided in part by the timing of customer orders. Despite an increasingly complex and dynamic geopolitical environment, given the year-to-date performance and our outlook for the remainder of the year, we are ti...

August 8, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 15, 2025 to stockholders of record at the close of business on August 29, 2025. About embecta embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innova...

August 8, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Report Fiscal Third Quarter 2025 Financial Results

embecta to Report Fiscal Third Quarter 2025 Financial Results PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 8, 2025. Those who would like to participate may access the live webcast , or access the teleconference ....

July 24, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.06
BLMN Bloomin' Brands...
PLAY Dave & Buster's... ... (+23)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

BLMN BLOOMIN' BRANDS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
NWL NEWELL BRANDS INC
NVR NVR INC.
LEN LENNAR CORPORATION CLASS A
KHC KRAFT HEINZ COMPANY
KBH KB HOME
JACK JACK IN THE BOX INC.
HD HOME DEPOT INC.
CHDN CHURCHILL DOWNS INCORPORATED
CCS CENTURY COMMUNITIES INC.
CAL CALERES INC.
AEO AMERICAN EAGLE OUTFITTERS INC.
DHI D.R. HORTON INC.
BC BRUNSWICK CORPORATION
CRI CARTER'S INC.
GES GUESS? INC.
LEG LEGGETT & PLATT INCORPORATED
SCVL SHOE CARNIVAL INC.
CARS CARS.COM INC.
FT FRANKLIN UNIVERSAL TRUST
MRNA MODERNA INC.
EMBC EMBECTA CORP
07/24/25 July 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch